Semantix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STIX research report →
Price Chart
About the company
Semantix Tecnologia Em Sistema de Informacao S. A. , a company established in 2007 and based in São Paulo, Brazil, specializes in offering expert consulting, educational programs, and comprehensive support.
- CEO
- Leonardo dos Santos Poca D'Agua
- IPO
- 2021
- Employees
- 7
- HQ
- São Paulo, SP, BR
Get TickerSpark's AI analysis on STIX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $117.67M
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.88
- Div Yield
- 0.00%
- Gross Margin
- 45.31%
- Op Margin
- -133.88%
- Net Margin
- -125.30%
- ROE
- -188.95%
- ROIC
- -61.78%
Latest fiscal year · YoY change
- Revenue
- $262.09M+23.8%
- Gross Profit
- $118.77M+37.8%
- Op Income
- $-350,894,000
- Net Income
- $-328,392,000-381.6%
- EPS
- $-4.71-447.7%
- OCF Growth
- -1194.2%
- FCF Growth
- -550.9%
- 52W High
- $4.74
- 52W Low
- $0.06
- 50D MA
- $0.60
- 200D MA
- $1.02
- Beta
- -0.37
- RSI (14)
- 34
- Avg Volume
- 52.62K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Semantix’s Q3 was a mix of sharp revenue decline and strong margin improvement as it shifted harder toward proprietary AI/SaaS and cost cuts.· November 8, 2023
- Net revenue was R$40 million, down 51% year over year and 17% sequentially, as the company deliberately did not renew low-margin third-party contracts.
- Proprietary SaaS revenue grew 41% year over year and rose to 37% of total revenue from 13% a year ago; management also said 53% of quarterly revenue came from intellectual property/proprietary products and AI consulting.
- Gross margin reached a record 62%, up 14 percentage points year over year, reflecting the better mix and cost-saving actions.
- Adjusted EBITDA was a loss of R$17 million with a negative 43% margin; cash and cash equivalents were R$111 million at September 30.
- Management said it will not provide specific revenue guidance for the rest of 2023, but reiterated a goal of operational cash generation in full-year 2024.
Reported third-quarter 2023 net revenue was R$40 million, down 51% year over year and 17% versus the prior quarter. Proprietary SaaS revenue grew 41% year over year and represented 37% of total revenue, while third-party software revenue fell 67% year over year and represented 47% of total revenue. Gross margin was 62%, up 14 percentage points year over year, and adjusted EBITDA was a loss of R$17 million with a negative 43% margin. Non-GAAP SG&A expenses declined 5% year over year, and cash and cash equivalents were R$111 million as of September 30; the company also said it paid R$9 million in bank loans during the quarter. For the rest of 2023, management declined to give specific revenue guidance, but said it expects the third-party software run-rate to stay at a similar level and reiterated a focus on proprietary SaaS and operational cash generation in 2024.
Leonardo Santos framed the quarter as validation of Semantix’s AI-first strategy, highlighting growth in AI revenue across agro, finance and health and the launch of new applications such as a retail product and ChatPharma for pharma customers. He emphasized that the company is shifting toward proprietary products, expanding its GenAI Hub, and building multiple AI applications with clients while keeping costs under control. His tone was upbeat and confident, repeatedly pointing to the improving margin profile and saying the company is moving toward operational cash generation in 2024.
Adriano Alcalde focused on the financial impact of the restructuring and the deliberate reduction in low-margin third-party software. He said annual total costs and expenses were reduced by 30% versus the annualized June 2023 level excluding third-party software, non-GAAP SG&A fell 5% year over year, gross margin rose to 62%, and adjusted EBITDA was a R$17 million loss. He also noted R$111 million in cash and cash equivalents, R$9 million of bank loan repayments in the quarter, and said the company is still seeing restructuring-related termination costs but expects the full benefit of efficiency actions in coming quarters.
Analyst Rudy Kessinger pressed management on how much third-party software revenue remains, whether proprietary SaaS growth can be sustained sequentially, and whether the company’s cash breakeven target had slipped. Management said third-party revenue is expected to stay at a similar level, but declined to provide formal guidance for either third-party or proprietary SaaS revenue, citing product development capacity, investment priorities, and uncertainty in renewals. On cash breakeven, management clarified the goal is operational cash generation in full-year 2024 and said the shift away from low-margin contracts should improve working capital and support that target.
The bull case from this call is that Semantix is successfully reshaping its revenue mix toward higher-margin proprietary SaaS and AI offerings, with proprietary revenue up 41% and gross margin at a record 62%. Management also described a strong pipeline, new product launches, and contract wins in financial services, agribusiness, health, and pharma, which suggests the AI strategy is resonating with customers.
The bear case is that total revenue fell sharply, adjusted EBITDA remained deeply negative, and management explicitly withheld revenue guidance because of macro headwinds and uncertainty around customer buying cycles. The shift away from low-margin third-party contracts improves margins, but it also pressures near-term revenue and leaves the company still dependent on successful execution, renewals, and product conversion to reach cash breakeven in 2024.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 0.8%
- Shares Outstanding
- 392.22M
- Float Shares
- 3.07M
of shares held by institutions
8 13F filers
Our STIX coverage
Recent articles, reports, and earnings notes.
No research on STIX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate STIX report →Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
businesswire.com · Apr 7
Atos to sell Latin American businesses to Brazil's Semantix
reuters.com · Dec 26
Atos Group has signed a binding agreement to sell its Atos operations in South America to the Brazilian company Semantix
globenewswire.com · Dec 26
Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome
businesswire.com · Dec 12
STIX Mint on Coinbase Surpasses 200K in 3 Days
globenewswire.com · Aug 20
STIX Teams Up with Coinbase for Special Mint
globenewswire.com · Jul 25
Why Is Semantix (STIX) Stock Down 47% Today?
investorplace.com · Apr 5
Semantix Announces Voluntary Delisting from the Nasdaq Global Market
globenewswire.com · Apr 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.